[Factors related to adjuvant ovarian function suppression in premenopausal breast cancer patients].

医学 依西美坦 三苯氧胺 乳腺癌 内科学 妇科 肿瘤科 佐剂 癌症
作者
Yue Liang,Xiaosong Chen,Jiayi Wu,Ou Huang,Yu Zong,Lijing Nie,Qiong Fang,Jian-Rong He,Li Zhu,Weiguo Chen,Yafen Li,Kunwei Shen
出处
期刊:Chinese journal of oncology [BioMed Central]
卷期号:38 (5): 357-62
标识
DOI:10.3760/cma.j.issn.0253-3766.2016.05.007
摘要

To analyze the applied condition of ovary function suppression (OFS) before and after joint analysis of TEXT and SOFT trials and SOFT trial, and to identify the relevant factors of OFS usage.The analysis was performed in premenopausal women with hormone receptor (HR) positive breast cancer receiving surgical treatment from Apr 2013 to Oct 2015 in Ruijin Hospital, Shanghai Jiaotong University School of Medicine. Adjuvant treatment strategy was made in the multidisciplinary team (MDT) meetings. We analyzed the applied condition of OFS before and after joint analysis, SOFT trial and its relevant factors.Among 454 patients, 114 (25.1%) patients received OFS. Before the results of joint analysis came out, all the patients (38/38) received OFS together with tamoxifen (TAM); after the results came out, clinicians began to put OFS with exemestane into practice, among 76 patients, 41(53.9%) patients received OFS with exemestane while 35 (46.1%) patients received OFS together with TAM. Before the results of SOFT trial came out, 71 out of 310 (22.9%) patients received OFS while 43 out of 144 (29.9%) patients received OFS after that. No significant difference was found between the proportion of patients receiving OFS before and after the results of SOFT trial came out (P=0.112). Age, histological grade, pN status, Ki-67 status, molecular subtype and acceptance of chemotherapy were correlated with OFS treatment (P<0.05). Age, tumor grade and pN were independent significant predictors of OFS usage.After the results of joint analysis came out, clinicians began to apply OFS with exemestane to premenopausal women with HR positive breast cancer. There is no significant difference between the proportion of patients receiving OFS before and after SOFT trial. Age, tumor grade and pN status are independent significant predictors of OFS treatment. Patients younger than 40, with histological grade Ⅱ or Ⅲ tumor and with pN1 or pN2 status are prone to receive OFS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1sunpf完成签到,获得积分0
刚刚
spf完成签到,获得积分0
1秒前
嘉深完成签到,获得积分10
1秒前
1秒前
亮仔完成签到,获得积分10
4秒前
6秒前
LEETHEO完成签到,获得积分10
6秒前
小蘑菇应助要减肥仰采纳,获得10
10秒前
张zz发布了新的文献求助10
11秒前
1h2ii3ooo关注了科研通微信公众号
11秒前
晨曦完成签到,获得积分10
12秒前
感动白开水完成签到,获得积分10
13秒前
热情嘉懿完成签到,获得积分10
13秒前
14秒前
Jasper应助哎呀采纳,获得10
15秒前
duoduo完成签到,获得积分10
17秒前
17秒前
化学小学生完成签到,获得积分10
18秒前
aaa完成签到,获得积分10
19秒前
土豪的颜发布了新的文献求助10
19秒前
20秒前
wyt123完成签到,获得积分10
21秒前
皮皮鲁发布了新的文献求助10
21秒前
mengzhonghunli完成签到,获得积分10
21秒前
22秒前
22秒前
在水一方应助Chaoli采纳,获得10
22秒前
Cc完成签到,获得积分10
23秒前
令尊是我犬子完成签到 ,获得积分10
24秒前
26秒前
Cc发布了新的文献求助10
26秒前
27秒前
31秒前
褚香旋完成签到,获得积分10
31秒前
31秒前
jergen发布了新的文献求助10
34秒前
褚香旋发布了新的文献求助10
35秒前
晶晶发布了新的文献求助10
36秒前
37秒前
刘玲完成签到 ,获得积分10
38秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1000
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
Photodetectors: From Ultraviolet to Infrared 500
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6359087
求助须知:如何正确求助?哪些是违规求助? 8173088
关于积分的说明 17212429
捐赠科研通 5414114
什么是DOI,文献DOI怎么找? 2865393
邀请新用户注册赠送积分活动 1842747
关于科研通互助平台的介绍 1690901